Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients

Endogenous IL-32 Controls Cytokine and HIV-1 Production

(2014) M. F. Nold et al.   JOURNAL OF IMMUNOLOGY

A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma

(2013) T. S. Plantinga et al.   CARCINOGENESIS

Novel insights into the biology of interleukin-32

(2013) Leo A. B. Joosten et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C

(2013) Carolina Scagnolari et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Inducible Interleukin 32 (IL-32) Exerts Extensive Antiviral Function via Selective Stimulation of Interferon λ1 (IFN-λ1)

(2013) Yongkui Li et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1

(2013) Yujing Huang et al.   Virology Journal

IFN-λ inhibits HIV-1 integration and post-transcriptional events in vitro, but there is only limited in vivo repression of viral production

(2012) Ren-Rong Tian et al.   ANTIVIRAL RESEARCH

Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection

(2012) Suyoung Bae et al.   CYTOKINE

HIV-1, interferon and the interferon regulatory factor system: An interplay between induction, antiviral responses and viral evasion

(2012) Giulia Marsili et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Increased interleukin-32 expression in chronic hepatitis B virus-infected liver

(2012) Qihuan Xu et al.   JOURNAL OF INFECTION

Innate immune interferon responses to Human immunodeficiency virus-1 infection

(2012) Rose Hughes et al.   REVIEWS IN MEDICAL VIROLOGY

Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps

(2011) A. Keswani et al.   ALLERGY

Proteinase 3-processed form of the recombinant IL-32 separate domain

(2011) Sun-Jong Kim et al.   BMB Reports

Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis

(2011) Alexander R. Moschen et al.   HEPATOLOGY

Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expressionof interleukin-32 controls the expression of the humanpapillomavirus oncogene

(2011) Sojung Lee et al.   IMMUNOLOGY

The Immunosuppressive Role of IL-32 in Lymphatic Tissue during HIV-1 Infection

(2011) A. J. Smith et al.   JOURNAL OF IMMUNOLOGY

Protection from RNA and DNA Viruses by IL-32

(2011) Jarod A. Zepp et al.   JOURNAL OF IMMUNOLOGY

Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy

(2011) Peter W. Hunt et al.   JOURNAL OF INFECTIOUS DISEASES

Inflammation-dependent secretion and splicing of IL-32  in rheumatoid arthritis

(2011) B. Heinhuis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics

(2010) John S. Albin et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Interleukin-32γ Enhances the Production of IL-6 and IL-8 in Fibroblast-Like Synoviocytes Via Erk1/2 Activation

(2010) Yong-Gil Kim et al.   JOURNAL OF CLINICAL IMMUNOLOGY

IL-32: A Host Proinflammatory Factor against Influenza Viral Replication Is Upregulated by Aberrant Epigenetic Modifications during Influenza A Virus Infection

(2010) W. Li et al.   JOURNAL OF IMMUNOLOGY

IL-32 Is a Host Protective Cytokine against Mycobacterium tuberculosis in Differentiated THP-1 Human Macrophages

(2010) X. Bai et al.   JOURNAL OF IMMUNOLOGY

Interferon-Lambda: A New Addition to an Old Family

(2010) Raymond P. Donnelly et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Human MxA Protein: An Interferon-Induced Dynamin-Like GTPase with Broad Antiviral Activity

(2010) Otto Haller et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction

(2010) Eric W. Refsland et al.   NUCLEIC ACIDS RESEARCH

Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus

(2010) Julia Diegelmann et al.   PLoS One

Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha

(2010) Carolina Scagnolari et al.   Virology Journal

Gene Expression of Nucleic Acid-Sensing Pattern Recognition Receptors in Children Hospitalized for Respiratory Syncytial Virus-Associated Acute Bronchiolitis

(2009) C. Scagnolari et al.   Clinical and Vaccine Immunology

Interleukin-32 Expression in the Pancreas

(2009) Atsushi Nishida et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Lambda Interferon Inhibits Human Immunodeficiency Virus Type 1 Infection of Macrophages

(2009) W. Hou et al.   JOURNAL OF VIROLOGY

IL-32-dependent effects of IL-1  on endothelial cell functions

(2009) C. A. Nold-Petry et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of the most active interleukin-32 isoform

(2008) Ji-Da Choi et al.   IMMUNOLOGY

Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication

(2008) Sahibzada T. Rasool et al.   IMMUNOLOGY LETTERS

HIV-1 Vif, APOBEC, and Intrinsic Immunity

(2008) Ritu Goila-Gaur et al.   Retrovirology